Kumar Rashmi
SEC CIK 1824720 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | Dir | 171.9K | — | $276.9K | 7 | 2022-06-02 | 2026-06-08 |
Most active insiders at MYGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Phanstiel S. Louise | Dir | $494.5K | — |
| 2 | Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| 3 | Kumar Rashmi | Dir | — | $66.8K |
| 4 | Bisaro Paul | Dir | $27.6K | — |
| 5 | Jampa Raj | CTO | — | — |
| 6 | Wheeler Benjamin Richard | CFO | — | — |
| 7 | Donnelly Brian J | Chief Commerical Off | — | — |
| 8 | Davis Mark Steven | Dir | — | — |
| 9 | Sikri Vishal | EVP, Commercial | — | — |
| 10 | Muzzey Dale | CSO | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-09 16:20 | 2026-06-08 | MYGN | MYRIAD GENETICS INC | Kumar Rashmi | Dir | S - Sale | $4.46 | -15.0K | 171.9K | -8% | -$66.8K |
| 2026-06-05 16:24 | 2026-06-04 | MYGN | MYRIAD GENETICS INC | Kumar Rashmi | Dir | A - Grant | $0.00 | +59.7K | 186.9K | +47% | $0 | |
| 2025-06-06 | 2025-06-05 | MYGN | MYRIAD GENETICS INC | Kumar Rashmi | Dir | A - Grant | $0.00 | +49.8K | 127.2K | +64% | $0 | |
| 2024-08-20 | 2024-08-19 | MYGN | MYRIAD GENETICS INC | Kumar Rashmi | Dir | S - Sale | $28.01 | -7,500 | 77.4K | -9% | -$210.1K | |
| 2024-06-07 | 2024-06-06 | MYGN | MYRIAD GENETICS INC | Kumar Rashmi | Dir | A - Grant | $0.00 | +15.7K | 84.9K | +23% | $0 | |
| 2023-06-02 | 2023-06-01 | MYGN | MYRIAD GENETICS INC | Kumar Rashmi | Dir | A - Grant | $0.00 | +15.2K | 69.2K | +28% | $0 | |
| 2022-06-03 | 2022-06-02 | MYGN | MYRIAD GENETICS INC | Kumar Rashmi | Dir | A - Grant | $0.00 | +17.3K | 54.0K | +47% | $0 |
Purchase Sale Sale after option exercise All abbreviations